title: Transformation of a human mixed GH-PRL adenoma cell population in response to long-term bromocriptine treatment.
abstract: A child was operated 3 times because of a recurrent growth hormone- and prolactin-producing pituitary adenoma. Between the operations she was treated for five years with bromocriptine. The characteristics of the tumour cell population collected after the last operation was now examined by electron microscopy, immunocytochemistry, and in tissue culture and compared to those of the primary tumour cells reported earlier. A prominent change was the reversal of the proportion of the densely and sparsely granulated cells in favour of the GH-type, densely granulated cells. These cells, some of them coexpressing PRL, did not essentially change their characteristics either in vivo or in culture. On the other hand, pleomorphous cells with smaller cytoplasmic area and prominent lysosomal structures represented the sparsely granulated population containing PRL or both PRL and GH. The morphological alteration of the PRL-type cells was also reflected in vitro. Hence, while GH-type cells prevail, at least a sub-population of PRL-type cells survives long-term bromocriptine administration. A shift in the incidence of the two cell types in favour of the GH-type cells explains the change in the endocrine status of the patient.
authors.affiliation: Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary.
authors.forename: E
authors.initials: E
authors.lastname: Bácsy
authors.forename: I
authors.initials: I
authors.lastname: Fazekas
authors.forename: F
authors.initials: F
authors.lastname: Slowik
authors.forename: E
authors.initials: E
authors.lastname: Pásztor
authors.forename: S
authors.initials: S
authors.lastname: Czirják
mesh_terms: D000236:Adenoma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D001971:Bromocriptine / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D046508:Culture Techniques; D005260:Female; D006727:Hormone Antagonists / Q000627:therapeutic use*; D019382:Human Growth Hormone / Q000378:metabolism; D006801:Humans; D009364:Neoplasm Recurrence, Local; D010911:Pituitary Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D011388:Prolactin / Q000378:metabolism
chemical_list: D006727:Hormone Antagonists; D019382:Human Growth Hormone; D001971:Bromocriptine; D011388:Prolactin